BackBack Shiva Pharmachem files DRHP to raise ₹900 crore via IPO
21 Aug 2023
• Mint
Shiva Pharmachem Share Price
DMAT
PUBLIC LIMITED
Price Chart
High
-
Low
-
Return
-
Buy Sell Shiva Pharmachem Unlisted Shares
As of November 13, 2026, Shiva Pharmachem Unlisted Shares are available at ₹0.00 per share, with a face value of ₹2.00 per share, a 52-week high of ₹0.00 and a 52-week low of ₹0.00. The minimum lot size is None shares, and the shares can be held in dematerialised form through NSDL and CDSL.
ISIN
INE471Z01020
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
2
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
10,62,03,000
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Sector
Health Care
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Specialty Chemicals
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Upcoming IPO
Category is defined as a class or division of things regarded as having particular shared characteristics.
About Shiva Pharmachem
Company Overview:
- Shiva Pharmachem is the largest manufacturer of acid and alkyl chlorides, by volume, in CY 2022 in India and a key player globally. The company has over 20 years of experience in the Indian specialty chemicals business. The company started its operations with chlorine chemistry as the core competency with a focus on the chlorination of acid and alcohols by thionyl chloride.
- Shiva Pharmachem has subsequently developed competencies in advanced intermediates involving complex chemistry and multi-step processes. The company manufactures the products at the facilities in Luna (Gujrat), Dahej SEZ (Gujrat), and Sajobabony (Hungary), and the company is backward integrated for most of the key products.
- Shiva Pharmachem is also experienced in handling hazardous chemistries (like chlorination and vapor phase reactions at high temperatures of 400 degrees and above). Also with the help of the R&D team, Shiva Pharmachem has developed in-house technology for all the products including bulk acid chlorides and specialty chemicals.
- The company offers over 100 specialized products, the product lines include aliphatic and aromatic chlorides, aliphatic and aromatic nitriles, alkoxy ketones, herbicide safeners, thiocarbamates, chloroformates, and isocyanates. The products have diversified applications across several industry sectors including agrochemicals, performance materials, disinfectants, pharmaceuticals, polymers, cosmetics, and others which helps the business against downturns in a particular industry.
- Shiva Pharmachem has a diverse customer base, it served 181 multinational and domestic companies in FY23 and sold the products to 22 countries outside India. Some of the key geographies in which the company sells its products include Germany, the United States, Switzerland, Italy, and Mexico.
- The company was incorporated on 18 March 1999, with its registered office on the 12th Floor, SHIVA, Sarabhai Complex, Dr. Vikram Sarabhai Marg, Vadiwadi Vadodara Vadodara GJ 390023 IN.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Shiva Pharmachem Media
News
Articles
Videos
Frequently Asked Question (FAQs)
The annual report of Shiva Pharmachem Ltd is available in the annual report section.
Lock-in period of Shiva Pharmachem Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Shiva Pharmachem Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Shiva Pharmachem Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
Yes, buying and selling of unlisted shares in India is 100% legal.